Research graph
References from Persistent Inflammation, Immunosuppression, and Catabolism Syndrome in Children: Associations With Outcomes in a Secondary Analysis of a 2019–2024 Cohort. Local targets link to admitted publications; unresolved targets remain external evidence.
Application of persistent inflammation, immunosuppression, and catabolism syndrome to critically ill children: Single-center retrospective cohort, 2019-2023.
10.1097/pcc.0000000000003625 · 2025 · External reference
Persistent inflammation, immunosuppression, and catabolism: Evolution of multiple organ dysfunction.
10.1089/sur.2015.184 · 2016 · External reference
Persistent inflammation, immunosuppression and catabolism syndrome (PICS) after polytrauma: A rare syndrome with major consequences.
10.3390/jcm9010191 · 2020 · External reference
Risk factors, biomarkers, and mechanisms for persistent inflammation, immunosuppression, and catabolism syndrome (PICS): A systematic review and meta-analysis.
10.1016/j.bja.2024.03.038 · 2024 · External reference
Pediatric sepsis phenotypes and outcome: 5-Year retrospective cohort in a single center in India (2017-2022).
10.1097/pcc.0000000000003449 · 2024 · External reference
Biomarker assessment of a high-risk, data-driven pediatric sepsis phenotype characterized by persistent hypoxemia, encephalopathy, and shock.
10.1097/pcc.0000000000003499 · 2024 · External reference
Pediatric sepsis phenotype in a single-center cohort covering 2010-2020: evolution in day 1 – Day 3 trajectory and potential prognostic value.
10.1097/pcc.0000000000003708 · 2025 · External reference
Derivation and validation of pediatric sepsis-associated acute kidney injury subphenotypes with prognostic relevance.
10.1097/pcc.0000000000003789 · 2025 · External reference
Plasma linoleic acid is associated with pediatric sepsis phenotype and acute kidney injury.
10.1097/pcc.0000000000003902 · 2026 · External reference
Persistent inflammation, immunosuppression and catabolism syndrome (PICS) in critically ill children is associated with clinical outcomes: A prospective longitudinal study.
10.1111/jhn.12798 · 2021 · External reference
Clinical criteria for persistent inflammation, immunosuppression, and catabolism syndrome: An exploratory analysis of optimal cut-off values for biomarkers.
10.3390/jcm11195790 · 2022 · External reference
Pediatric persistent inflammation, immunosuppression, and catabolism syndrome prevalence in sepsis-related mortalities: A 23-year institutional history.
10.1016/j.chest.2023.05.002 · 2023 · External reference
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies.
10.1016/s0140-6736(07)61602-x · 2007 · External reference
Early biomarker signatures in surgical sepsis.
10.1016/j.jss.2022.04.052 · 2022 · External reference
Part 14: pediatric advanced life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
2010 · External reference
Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: A combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function.
10.1002/(sici)1097-0142(19991101)86:9<1818::aid-cncr25>3.0.co;2-0 · 1999 · External reference
Some diagnostic methods for Cox regression models through hazard smoothing.
10.2307/2531633 · 1990 · External reference
PRISM III: An updated Pediatric Risk of Mortality score.
10.1097/00003246-199605000-00004 · 1996 · External reference
Organ dysfunction in children with blood culture-proven sepsis: Comparative performance of four scores in a national cohort study.
10.1097/pcc.0000000000003388 · 2024 · External reference
The zonulin pathway as a potential mediator of gastrointestinal dysfunction in critical illness.
10.1097/pcc.0000000000002985 · 2022 · External reference
Multi-compartmental profiling of bacterial and host metabolites identifies intestinal dysbiosis and its functional consequences in the critically ill child.
10.1097/ccm.0000000000003841 · 2019 · External reference
Profiling gut microbiota and bile acid metabolism in critically ill children.
10.1038/s41598-022-13640-0 · 2022 · External reference
Temporal and spatial changes in the microbiome following pediatric severe traumatic brain injury.
10.1097/pcc.0000000000002929 · 2022 · External reference
Lower gastrointestinal tract dysbiosis in persistent critical illness: A systematic review.
10.1099/jmm.0.001888 · 2024 · External reference
A review of gut failure as a cause and consequence of critical illness.
10.1186/s13054-025-05309-7 · 2025 · External reference
Automated calculator for the pediatric sequential organ failure assessment score: Development and external validation in a single-center 7-year cohort, 2015-2021.
10.1097/pcc.0000000000003458 · 2024 · External reference
Dynamic prediction of mortality using longitudinally measured pediatric sequential organ failure assessment scores: A joint modeling approach.
10.1097/pcc.0000000000003457 · 2024 · External reference
Assessing bedside measures of autonomic nervous system dysregulation in the PICU.
10.1038/s41390-024-03778-0 · 2025 · External reference
Heart rate variability discriminates outcome after pediatric cardiac arrest.
10.1097/pcc.0000000000003904 · 2026 · External reference
Heart rate variability in the prediction of mortality: A systematic review and meta-analysis of healthy and patient populations.
10.1016/j.neubiorev.2022.104907 · 2022 · External reference
Heart rate variability as a marker and predictor of inflammation, nosocomial infection, and sepsis – A systematic review.
10.1016/j.autneu.2023.103116 · 2023 · External reference
Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier.
10.1172/jci149633 · 2021 · External reference
Zonulin as a biomarker and potential therapeutic target in multisystem inflammatory syndrome in children.
10.1172/jci151467 · 2021 · External reference
Regulation of intestinal permeability in health and disease: Possible therapeutic applications.
10.1016/j.arcmed.2025.103321 · 2026 · External reference